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Introduction 
Abuse of anabolic steroids (AS) is a worldwide 
problem. Athletes and teenagers striving for improved 
results or better looks risk their physical and mental 
health. Numerous ide-effects of AS on hepatic, renal 
and genital function have been described. However, it 
is not yet fully understood how AS effects the 
cardiovascular system. 
AS increase the serum level of low density lipopro- 
teins (LDL) and decrease the serum level of high 
density lipoproteins (HDL). 1 AS affect a number of 
haemostatic functions, such as enhanced platelet 
aggregation, 2"3increased synthesis of procoagulant 
factors 4 and impaired fibrinolysis. 5 Several papers 
regarding coronary events in athletes using AS have 
been published. 6'7 However, we have found only one 
previous report concerning peripheral arterial occlu- 
sive disease, s 
Case Reports 
Case 1 
A 37-year-old male athlete and bodybuilder, who had 
used AS in periods during the last 10 years was 
admitted with sudden onset of severe pain in his left 
leg. Angiography showed occlusion of all major 
arteries of the leg. Heparin infusion was given for 3 
weeks. This resulted in relief of rest pain. When he 
was discharged he had claudication and a walking 
*Please address al..1 correspondence to: M~rtin Falkenberg, Depart- 
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distance of approximately 100-200 metres. This 
remained constant over time. Two years later he was 
admitted to our clinic. He had no family history of 
cardiovascular disease and had never smoked 
tobacco. The maximum walking distance measured on 
a treadmill was 100 metres. No pulses could be felt in 
his left groin. Ankle pressures were 60 mmHg on the 
left side and 140 mmHg on the right side compared to 
a brachial pressure of 135 mmHg. Routine laboratory 
tests including haemoglobin (145 g/l) and platelets 
(268 x 109/1) were normal. Angiography demon- 
strated a long occlusion of the left external iliac, 
common femoral superficial femoral and popliteal 
arteries (Fig. 1). The only patent arteries visualised 
below the groin were the deep femoral artery and the 
anterior tibial artery. The arteries of the contralateral 
leg were normal with no sign of atherosclerotic 
disease. 
The patient was treated with a bypass operation. An 
8 mm PTFE graft from the common iliac to the deep 
femoral artery was used, in combination with a 
femorotibial bypass using an in situ saphenous vein 
graft. The distal reconstruction occluded within a 
week and was successfully reconstructed with a 
composite graft. The patient was discharged from the 
hospital free of symptoms after 1 week. Eighteen 
months later he was readmitted due to gradual return 
of claudication. A repeat angiogram confirmed that 
both reconstructions had occluded. Reoperation with 
insertion of a new jump-graft from the common iliac 
to the deep femoral arterN with further extension to 
the fibular and posterior tibial arteries, was per- 
formed. For the distal reconstruction a reversed 
saphenous vein graft from the contralateral leg was 
used. This reconstruction ccluded after 3 weeks. No 
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attempts to further eoperations were made, and the 
patient was discharged with claudication. One year 
later his situation is stable with a severe claudication 
and a maximum walking distance of 50 metres, but no 
rest pain. 
Case 2 
A 27-year-old male who smoked 20 cigarettes per day 
had chronic back-pain due to a traffic accident 8years 
ago and was overconsuming Treo-Comp® (acetic 
salicylic acid, ASA, 500 mg, codeine 30 mg, caffeine 50 
mg), approximately 8 tablets/day. Except for this, he 
was previously healthy and had no family history of 
cardiovascular disease. He was an active bodybuilder 
and had used oral AS for the last 13 months. The AS 
were consumed uring three periods with increasing 
doses. During the last period, which lasted for about 2 
months he had used methandione 50 mg/day, stano- 
zolol 30 mg/day and oxymetholone 50mg/day. Two 
weeks after finishing this period he experienced 
sudden onset of pain in his right calf and foot. He was 
referred to the county hospital, where he spent the 
night. He was sent home the following morning, and 
the pain in his leg was diagnosed as an effect of 
overtraining. Measurement of arterial toe-pressure 
arranged by his GP was found to be 20 mmHg in his 
right foot and 115 mmHg in the left (reference > 90 
mmHg). A colour-coded ultrasound examination 
revealed occlusion of the upper and middle thirds of 
all the arteries in the lower leg. The preliminary 
diagnosis was arterial thrombosis. Haemoglobin con- 
centration and platelet numbers were within normal 
limits (145 g/l, 281 × 109/1). Thrombolysis was 
attempted with an infusion of streptokinase, without 
any clinical improvement. Angiography confirmed 
occlusion of all three arteries of the lower leg with 
only the distal parts of the anterior and posterior tibial 
arteries patent (Fig. 2). No signs of anatomical 
abnormalities of the popliteal artery could be demon- 
strated. A popliteodistal bypass was planned. How- 
ever, at surgical exploration o macroscopic signs of 
arterial disease could be seen, and thrombectomies on 
both tibial arteries could easily be performed. Intra- 
operative angiography showed no residual thrombi or 
irregularities of the vessel walls. The arteriotomies 
were closed with vein patches. Both vessels occluded 
within 6 h. A reoperation with a bypass from the 
popliteal artery to the most distal portion of the 
posterior tibial artery was then performed using a 
reversed saphenous vein graft. Despite this recon- 
struction being patent he developed progressive gan- 
grene of the distal foot leading to a fore-foot 
amputation. 
Laboratory studies of the coagulation profile 3 
months after the operation revealed only minor 
abnormalities with low protein S, 28% (ref 40-100%), 
and a slight increase of von Willebrand's factor, 2.80 
IE/ml (ref 0.40-2.00 IE/ml). All other laboratory 
investigations including antithrombin, protein C, acti- 
vated protein C resistance, plasminogen, tissue plas- 
minogen activator, plasminogen activator inhibitor 
type 1, prothrombine complex, fibrinogen and throm- 
bin time were normal. 
Fig. 1. Case 1. Angiography showing occlusion of the external i iac 
artery and the superficial femoral artery. 
Discussion 
From a cardiovascular point of view the side effects of 
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AS related to haemostatic mechanisms and vascular 
wall biology are of special interest. Platelets are 
important in the pathogenesis of cardiovascular dis- 
ease. Platelet numbers, function and aggregation are 
effected by androgens, z'3 Changes in coagulation 
factor synthesis 4 and fibrinolytic activity 5 have also 
been reported. AS increase low density lipoprotein 
(LDL) and decrease high density lipoprotein (HDL) 
level s causing an adverse lipid profile. Increased 
insulin resistance and diminished glucose tolerance 
have been demonstrated in powerlifters ingesting AS. 9 
Increased LDL and insulin resistance are associated 
with impaired fibrinolysis, l°'n Recent reports describe 
myocardial infarction, in young and otherwise healthy 
persons using AS. 6'7 These studies suggest a link 
between the use of AS and an increased risk of 
cardiovascular disease, lz
Our first patient was initially considered to be 
suffering from Burger's disease. The fact that he had 
never smoked does not support that diagnosis. His 
angiogram showed no signs of atherosclerosis. In the 
second patient, smoking was an extra risk for arterial 
disease. However, acute arterial occlusion at the age of 
27 without any other isk factors is extremely rare. His 
medication (containing ASA), should also be pro- 
tective against thromboembolic events. At exploration 
no signs of primary arterial disease, such as calcifica- 
tion or increase of wall thickness could be detected. 
Both patients had unusual anatomic sites of their 
arterial thrombosis. 
The specific cause of arterial thrombosis in these 
two patients cannot be proven, but their abuse ofAS is 
likely to have been a predisposing factor. The mecha- 
nism could be due to a hypercoagulable state, 
increased platelet aggregation and impaired fibrinol- 
ysis. The failure of reconstructive surgery and pro- 
tracted course of ischaemia in both our patients eems 
to justify a conservative attitude regarding reconstruc- 
tion or amputation i these cases. 
Fig. 2. Angiography revealing occlusions of the anterior and 
posterior tibial arteries and the fibular artery of the patients right 
teg. 
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